Literature DB >> 4020967

Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice.

D L Lodmell, L C Ewalt.   

Abstract

Seven strains of mice were examined to determine why susceptibility differences and variations in clinical central nervous system (CNS) disease occurred among these animals after intraperitoneal inoculation of street rabies virus (SRV). Trace experiments for infectious virus indicated that these differences were associated with restriction of virus replication within the CNS. Limitation of viral replication appeared to correlate with the antibody response in that prominent serum anti-SRV neutralizing antibody titers were detected in resistant strains, whereas susceptible strains produced minimal amounts of antibody until their death. The importance of the immune response was reaffirmed with cyclophosphamide studies in that all resistant SJL/J mice died after immunosuppressive treatment. In contrast, cyclophosphamide-treated SJL/J mice whose immune systems were reconstituted with either unfractionated immune spleen cells or with sera 24 h after SRV inoculation survived a lethal dose of SRV. More importantly, immunosuppressed SJL/J and immunodeficient athymic mice were protected when reconstituted with immune serum 72 h after SRV inoculation, a time in which infectious virus was detected in the spinal cords of some mice but was not present in the peritoneal cavity. Additional studies showed that antibody in the cerebrospinal fluid was unimportant in the resistance of mouse strains which remained clinically asymptomatic, but it appeared to be associated with the survival of mice which developed clinical CNS disease. Furthermore, CNS resistance to intranasal or intracerebral inoculation with challenge virus standard rabies virus developed as early as 5 days post-intraperitoneal inoculation of SRV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020967      PMCID: PMC255063     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Hydrophobia following the bite of apparently healthy dogs.

Authors:  A M YURKOVSKY
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1962

2.  Defective interfering particles modulate VSV infection of dissociated neuron cultures.

Authors:  G Faulkner; M Dubois-Dalcq; E Hooghe-Peters; H F McFarland; R A Lazzarini
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

3.  Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response.

Authors:  H L Lipton; F Gonzalez-Scarano
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

4.  The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells.

Authors:  A Miller; H C Morse; J Winkelstein; N Nathanson
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  Immunofluorescent examination of the skin of rabies-infected animals as a means of early detection of rabies virus antigen.

Authors:  D C Blenden; J F Bell; A T Tsao; J U Umoh
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

6.  Chemical and immunological analysis of the rabies soluble glycoprotein.

Authors:  B Dietzschold; T J Wiktor; W H Wunner; A Varrichio
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

7.  Intermittent excretion of rabies virus in the saliva of a dog two and six months after it had recovered from experimental rabies.

Authors:  M Fekadu; J H Shaddock; G M Baer
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

8.  Murine resistance to street rabies virus: genetic analysis by testing second-backcross progeny and verification of allelic resistance genes in SJL/J and CBA/J mice.

Authors:  D L Lodmell; B Chesebro
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine.

Authors:  G S Turner
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

10.  Influence of cell type and virus upon lysis of rabies virus-infected cells by antibody and complement.

Authors:  D L Lodmell; Y T Arai; L C Ewalt
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

View more
  14 in total

Review 1.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Immune sera and antiglycoprotein monoclonal antibodies inhibit in vitro cell-to-cell spread of pathogenic rabies viruses.

Authors:  D L Lodmell; L C Ewalt
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus.

Authors:  L L Perry; D L Lodmell
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors:  K J Hasenkrug; D M Brooks; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

5.  Cells with natural killer activity in human rabies.

Authors:  T Panpanich; T Hemachudha; S Piyasirisilp; S Manatsathit; H Wilde; P Phanuphak
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

6.  Paralysis of street rabies virus-infected mice is dependent on T lymphocytes.

Authors:  M Sugamata; M Miyazawa; S Mori; G J Spangrude; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence.

Authors:  N B Ray; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Vaccinia virus recombinants expressing rabiesvirus glycoprotein protect against rabies.

Authors:  J Esposito; K Brechling; G Baer; B Moss
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

9.  Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro.

Authors:  D L Lodmell; J J Esposito; L C Ewalt
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.

Authors:  Anirban Roy; D Craig Hooper
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.